On November 18, Ping An CSI Medical Innovation ETF (516820) closed down 1.69%, with a turnover of 61.2505 million yuan.
Healthcare Innovation ETF (516820) was established on June 9, 2021, and the full name of the fund is Ping An CSI Pharmaceutical and Medical Device Innovation Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as Ping An CSI Medical Innovation ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the Medical Innovation ETF (516820) is based on the return rate of the CSI Pharmaceutical and Medical Device Innovation Index.
In terms of scale, as of November 15, the latest share of medical innovation ETF (516820) was 4.549 billion shares, and the latest scale was 1.612 billion yuan. Looking back on December 29, 2023, the share of the Medical Innovation ETF (516820) was 2.990 billion shares, with a scale of 1.226 billion yuan. That is, the share of the fund has increased by 52.13% and the scale has increased by 31.50% since the beginning of this year.
In terms of liquidity, as of November 18, the cumulative turnover of medical innovation ETF (516820) in the past 20 trading days was 1.630 billion yuan, with an average daily turnover of 81.4797 million yuan, and since the beginning of this year, the cumulative turnover in 211 trading days has been 7.751 billion yuan, with an average daily turnover of 36.7358 million yuan.
The
current fund manager of Healthcare Innovation ETF (516820) is Weng Xin. Weng Xin has managed (or intends to manage) the fund since December 27, 2023, with a return of -11.16% during his tenure.
According to the latest regular report, the heavy stocks of the Medical Innovation ETF (516820) include WuXi AppTec, Aier Ophthalmology, Mindray Medical, United Imaging Healthcare, Zhifei Biotech, Kelun Pharmaceutical, Changchun High-tech, Aimeike, Huitai Medical, and Pharmaron, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 603259 | WuXi AppTec | 10.72% | 2,933,401,400 | |
| 300015 | Aier Ophthalmology | 10.07% | 9,068,0014 | million |
| 300760 | Mindray Medical | 8.57% | 419,30123 | million |
| 688271 | United Imaging Medical | 5.64% | 631,780,854,000||
| 300122 | Zhifei Biotech | 5.45% | 2.338 million | 78.0435 million |
| 002422 | Kelun Pharmaceutical | 4.86% | 2.1779 million | 69.6928 million |
| 000661 | Changchun High-tech | 4.75%, | 619,668,090,600||
| 300896 | Aimeike | , 4.72%, | 287,367,682,200 | |
| 688617 | Huitai Medical | 4.11% | 144,0058,940,700 | |
| 300759 | Pharmaron | 3.65% | 1,722,952,291,500 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
